Qureight
End-to-end imaging company for clinical trials with a focus on lung and heart disease.
$20MSeries B
Role not disclosedLoading investors…
Loading investors…
Activity from announced rounds
End-to-end imaging company for clinical trials with a focus on lung and heart disease.
Profiles the human immune system at scale using multi-omic analysis and machine learning to transform disease diagnosis and treatment